Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

577 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cytomegalovirus prevention strategies in seropositive kidney transplant recipients: an insight into current clinical practice.
Fernández-Ruiz M, Arias M, Campistol JM, Navarro D, Gómez-Huertas E, Gómez-Márquez G, Díaz JM, Hernández D, Bernal-Blanco G, Cofan F, Jimeno L, Franco-Esteve A, González E, Moreso FJ, Gómez-Alamillo C, Mendiluce A, Luna-Huerta E, Aguado JM; OPERA Study Group. Fernández-Ruiz M, et al. Among authors: aguado jm. Transpl Int. 2015 Sep;28(9):1042-54. doi: 10.1111/tri.12586. Epub 2015 Apr 23. Transpl Int. 2015. PMID: 25864986 Free article.
Prospective randomized trial of efficacy of ganciclovir versus that of anti-cytomegalovirus (CMV) immunoglobulin to prevent CMV disease in CMV-seropositive heart transplant recipients treated with OKT3.
Aguado JM, Gomez-Sanchez MA, Lumbreras C, Delgado J, Lizasoain M, Otero JR, Rufilanchas JJ, Noriega AR. Aguado JM, et al. Antimicrob Agents Chemother. 1995 Jul;39(7):1643-5. doi: 10.1128/AAC.39.7.1643. Antimicrob Agents Chemother. 1995. PMID: 7492123 Free PMC article. Clinical Trial.
Ganciclovir prophylaxis decreases frequency and severity of cytomegalovirus disease in seropositive liver transplant recipients treated with OKT3 monoclonal antibodies.
Lumbreras C, Otero JR, Herrero JA, Gomez R, Lizasoain M, Aguado JM, Colina F, Garcia I, Moreno E, Noriega AR. Lumbreras C, et al. Among authors: aguado jm. Antimicrob Agents Chemother. 1993 Nov;37(11):2490-2. doi: 10.1128/AAC.37.11.2490. Antimicrob Agents Chemother. 1993. PMID: 8285641 Free PMC article.
Prophylaxis of cytomegalovirus disease with ganciclovir or anti-CMV immunoglobulin in renal transplant recipients who receive antilymphocytic antibodies as induction therapy.
Morales E, Andrés A, González E, Herrero JC, Muñoz MA, Ortiz M, Espejo B, Lumbreras C, Morales JM, Aguado JM. Morales E, et al. Among authors: aguado jm. Transplant Proc. 2002 Feb;34(1):73-4. doi: 10.1016/s0041-1345(01)02671-9. Transplant Proc. 2002. PMID: 11959191 No abstract available.
577 results